Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership1,010,606 shares
Latest Disclosed Value $ 140,848,158
Macquarie Group Ltd reports 8.88% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 1,010,606 shares of Gilead Sciences, Inc. (US:GILD) valued at $140,848,158 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,109,148 shares of Gilead Sciences, Inc.. This represents a change in shares of -8.88% during the quarter. The current value of the position is $130,358,068 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,010,606 -98,542 -8.88 140,848 3.46 0.6558
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 1,109,148 -479,391 -30.18 136,137 -22.79 0.5950
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 1,588,539 146,312 10.14 176,328 10.27 0.2058
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 1,442,227 -59,485 -3.96 159,900 -4.97 0.1961
2025-08-14 2025-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,501,712 46,878 3.22 168,267 29.52 0.2089
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,572,077 117,243 160,398 0.1310
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,454,834 60,957 4.37 129,918 11.17 0.1576
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,393,877 152,296 12.27 116,863 37.19 0.1261
2024-08-09 2024-06-30 13F GILEAD SCIENCES COM 375558103 1,241,581 -17,203 -1.37 85,185 -7.61 0.0977
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,258,784 5,592 0.45 92,205 -9.18 0.1046
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,253,192 82,982 7.09 101,521 15.77 0.1173
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,170,210 8,411 0.72 87,696 -2.06 0.1102
2023-10-27 2023-06-30 13F/A-2 GILEAD SCIENCES COM 375558103 1,161,799 -23,903 -2.02 89,540 -8.98 0.1024
2023-10-12 2023-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,161,799 -23,903 89,540 0.0900
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 1,161,799 -23,903 89,540 0.0908
2023-06-01 2023-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,185,702 55,231 4.89 98,377 1.37 0.1169
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 1,185,702 55,231 98,377 0.0903
2023-02-21 2022-12-31 13F GILEAD SCIENCES COM 375558103 1,130,471 12,401 1.11 97,050 40.71 0.1146
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 1,118,070 12,509 1.13 68,974 0.94 0.0846
2022-08-17 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,105,561 -3,884 -0.35 68,335 3.61 0.0767
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 1,105,561 -3,884 68,335 0.0245
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 1,109,445 459,138 70.60 65,957 39.68 0.0502
2022-02-11 2021-12-31 13F Gilead Sciences COM 375558103 650,307 4,284 0.66 47,220 4.64 0.0393
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 646,023 277,434 75.27 45,125 77.78 0.0385
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 368,589 112,970 44.19 25,382 53.63 0.0208
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 255,619 -110,145 -30.11 16,521 -22.47 0.0234
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 365,764 6,000 1.67 21,310 -6.26 0.0311
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 359,764 22,409 6.64 22,733 -12.42 0.0385
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 337,355 -76,376 -18.46 25,956 -16.08 0.0447
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 413,731 14,395 3.60 30,931 19.20 0.0635
2020-03-18 2019-12-31 13F/A-2 GILEAD SCIENCES COM 375558103 399,336 5,806 1.48 25,948 4.03 0.0370
2020-02-28 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 399,336 0 25,948 0.0375
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 399,336 5,806 25,948 32,562.5410
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 393,530 -805 -0.20 24,943 -6.38 0.0418
2019-11-06 2019-06-30 13F/A-2 GILEAD SCIENCES COM 375558103 394,335 -8,777 -2.18 26,642 1.66 0.0449
2019-09-24 2019-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 394,335 0 26,642 0.0453
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 394,335 -8,777 26,642
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 403,112 -17,197 -4.09 26,206 -0.32 0.0447
2019-02-15 2018-12-31 13F GILEAD SCIENCES COM 375558103 420,309 -22,993 -5.19 26,290 -23.19 0.0508
2018-11-15 2018-09-30 13F GILEAD SCIENCES COM 375558103 443,302 28,450 6.86 34,228 16.47 0.0558
2019-03-21 2018-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 414,852 29,375 7.62 29,389 1.13 0.0507
2018-08-14 2018-06-30 13F GOLDMAN SACHS GROUP COM 375558103 414,852 29,375 29,389
2018-05-11 2018-03-31 13F GILEAD SCIENCES COM 375558103 385,477 -9,677 -2.45 29,062 4.87 0.0530
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 395,154 -84,178 -17.56 27,712 -28.64 0.0490
2017-11-08 2017-09-30 13F GILEAD SCIENCES COM 375558103 479,332 100,741 26.61 38,836 44.93 0.0697
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 378,591 -59,556 -13.59 26,797 -9.95 0.0490
2017-05-15 2017-03-31 13F Gilead Sciences COM 375558103 438,147 -54,603 -11.08 29,759 -15.66 0.0541
2017-03-30 2016-12-31 13F/A-1 Gilead Sciences COMMON 375558103 492,750 -18,391 -3.60 35,285 -12.75 0.0675
2017-02-15 2016-12-31 13F Gilead Sciences Common Stock 375558103 492,750 35,285
2016-11-15 2016-09-30 13F Gilead Sciences Common Stock 375558103 511,141 -71,976 -12.34 40,441 -16.86 0.0778
2016-09-14 2016-06-30 13F/A-1 Gilead Sciences Common Stock 375558103 583,117 -47,567 -7.54 48,644 -16.04 0.0955
2016-08-15 2016-06-30 13F Gilead Sciences Common Stock 375558103 583,117 48,644
2016-05-16 2016-03-31 13F Gilead Sciences Common Stock 375558103 630,684 -63,653 -9.17 57,934 -17.54 0.1167
2016-02-16 2015-12-31 13F Gilead Sciences Common Stock 375558103 694,337 -53,070 -7.10 70,260 -4.26 0.1442
2015-11-16 2015-09-30 13F Gilead Sciences Common Stock 375558103 747,407 -4,997 -0.66 73,387 -16.69 0.1573
2015-08-21 2015-06-30 13F/A-1 Gilead Sciences COM 375558103 752,404 -266,895 -26.18 88,091 -11.93 0.1744
2015-08-14 2015-06-30 13F Gilead Sciences COM 375558103 752,404 88,091
2015-05-18 2015-03-31 13F Gilead Sciences COM 375558103 1,019,299 -10,269 -1.00 100,024 3.07 0.1963
2015-02-17 2014-12-31 13F GILEAD SCIENCES COMMON 375558103 1,029,568 -92,044 -8.21 97,046 -18.72 0.2002
2014-11-14 2014-09-30 13F Gilead Sciences COM 375558103 1,121,612 -147,993 -11.66 119,396 13.43 0.2561
2014-08-14 2014-06-30 13F GILEAD SCIENCES COMMON 375558103 1,269,605 224,375 21.47 105,263 42.12 0.2348
2014-05-15 2014-03-31 13F Gilead Sciences Common Stock 375558103 1,045,230 -34,651 -3.21 74,065 -8.73 0.1279
2014-02-14 2013-12-31 13F Gilead Sciences Common Stock 375558103 1,079,881 -7,023 -0.65 81,149 18.81 0.1455
2013-11-14 2013-09-30 13F GILEAD SCIENCES INC COM Common Stock 375558103 1,086,904 -56,485 -4.94 68,304 16.65 0.1336
2013-08-16 2013-06-30 13F/A-1 GILEAD SCIENCES INC COM Common 375558103 1,143,389 1,143,389 58,557 0.1277
2013-08-14 2013-06-30 13F GILEAD SCIENCES INC COM Common 375558103 1,143,389 58,557 0.1277
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.